Goldman Sachs
IPSC icon

Goldman Sachs’s Century Therapeutics IPSC Stock Holding History

Goldman Sachs’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$476K Buy
+210,482
New +$443K ﹤0.01% 5633
2025
Q4 		– Sell
-60,682
Closed -$30.2K – 6624
2025
Q3 		$30.2K Sell
60,682
-215,296
-78% -$116K ﹤0.01% 6217
2025
Q2 		$154K Buy
275,978
+96,343
+54% +$51.7K ﹤0.01% 5728
2025
Q1 		$85.5K Buy
179,635
+38,052
+27% +$28.6K ﹤0.01% 5817
2024
Q4 		$143K Buy
141,583
+33,463
+31% +$45.6K ﹤0.01% 5700
2024
Q3 		$185K Buy
108,120
+37,314
+53% +$73.1K ﹤0.01% 5480
2024
Q2 		$181K Buy
70,806
+31,523
+80% +$99.6K ﹤0.01% 5295
2024
Q1 		$164K Sell
39,283
-5,342
-12% -$22.6K ﹤0.01% 5159
2023
Q4 		$148K Sell
44,625
-3,653
-8% -$6.66K ﹤0.01% 5226
2023
Q3 		$96.6K Buy
48,278
+5,067
+12% +$13.5K ﹤0.01% 5189
2023
Q2 		$137K Sell
43,211
-9,757
-18% -$31.5K ﹤0.01% 5297
2023
Q1 		$184K Buy
52,968
+22,818
+76% +$100K ﹤0.01% 5328
2022
Q4 		$155K Buy
30,150
+9,094
+43% +$85.8K ﹤0.01% 5382
2022
Q3 		$208K Sell
21,056
-4,712
-18% -$49.6K ﹤0.01% 5462
2022
Q2 		$216K Buy
25,768
+5,022
+24% +$49.3K ﹤0.01% 5610
2022
Q1 		$261K Buy
20,746
+2,091
+11% +$27.7K ﹤0.01% 5736
2021
Q4 		$296K Buy
+18,655
New +$350K ﹤0.01% 5677
2021
Q3 		– Sell
-52,808
Closed -$1.55M – 6357
2021
Q2 		$1.55M Buy
+52,808
New +$1.34M ﹤0.01% 4420

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Goldman Sachs's IPSC Position: Q1 2026 in Review

Goldman Sachs opened a new position in Century Therapeutics (IPSC) in Q1 2026: 210,482 shares worth $476K. The stake represents ﹤0.01% of the portfolio and ranks #5633 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in IPSC as recently as Q3 2025.

Goldman Sachs first reported a position in IPSC in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.55M in Q2 2021. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Goldman Sachs held 210,482 shares of Century Therapeutics worth $476K as of Q1 2026.
  • Century Therapeutics was a new Goldman Sachs position in Q1 2026.
  • Century Therapeutics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #5633 holding.
  • Goldman Sachs first reported a position in Century Therapeutics in Q2 2021 and has held it in 18 quarters since.
  • Goldman Sachs's Century Therapeutics position peaked at $1.55M in Q2 2021.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.